Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
26
×
drugs
26
×
life sciences
national blog main
clinical trials
boston blog main
fda
national top stories
san francisco blog main
new york blog main
san diego blog main
san diego top stories
san francisco top stories
boston top stories
national
new york top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
texas top stories
detroit blog main
detroit top stories
seattle blog main
seattle top stories
texas blog main
wisconsin blog main
wisconsin top stories
boston
deals
innovation
investing
novartis
pfizer
amgen
astrazeneca
What
drug
medicines
new
drugs
fda
cells
life
medical
medicine
plans
regulatory
bio
biological
biotech
brexit
charting
choppy
company
course
dynamic
end
humans
latest
long
period
post
produce
regulation
reveals
roundup
san
sciences
therapies
transition
uk
alnylam
alzheimer’s
announced
annual
approval
Language
unset
unknown
Current search:
biotech
×
drugs
×
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
4 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
@xconomy.com
5 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@venturebeat.com
7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs